Literature DB >> 7066669

Recurrent inhibition of alpha-motoneurons in patients with upper motor neuron lesions.

R Katz, E Pierrot-Deseilligny.   

Abstract

The recurrent inhibition of alpha-motoneurons by Renshaw cells, brought about by a conditioning reflex discharge, was estimated by measuring the amplitude of a test reflex which involved only those soleus motoneurons which had already fired in response to the conditioning volley. The results obtained in 95 patients with upper motor neuron disease and in 31 normal subjects were compared. At rest, there was no evidence for a decrease in the excitability of Renshaw cells: on the contrary, recurrent inhibition, if it changed at all, was increased in 55 out of 95 patients. In most patients the changes in Renshaw cells excitability which occur during postural or voluntary contractions in normal subjects were not found. We conclude that changes in recurrent inhibition are not responsible for the hyperexcitability of the stretch reflex which characterizes human spasticity. On the other hand, the paralysis of the supraspinal control of Renshaw cells, which normally accompanies voluntary movements, could account in part for two difficulties exhibited by spastic patients: in grading the strength of a muscular contraction, and in regulating reciprocal Ia inhibition according to the requirements of a voluntary movement.

Entities:  

Mesh:

Year:  1982        PMID: 7066669     DOI: 10.1093/brain/105.1.103

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Recurrent inhibition in patients with a lesion of the central nervous system.

Authors:  E B Lyubchinskii; R S Person; R E Pantseva
Journal:  Neurosci Behav Physiol       Date:  1991 Jan-Feb

2.  Short-term effects of functional electrical stimulation on spinal excitatory and inhibitory reflexes in ankle extensor and flexor muscles.

Authors:  Aiko K Thompson; Brian Doran; Richard B Stein
Journal:  Exp Brain Res       Date:  2005-11-30       Impact factor: 1.972

3.  Trends in the pathophysiology and pharmacotherapy of spasticity.

Authors:  J Noth
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

4.  Repetitive common peroneal nerve stimulation increases ankle dorsiflexor motor evoked potentials in incomplete spinal cord lesions.

Authors:  Aiko K Thompson; Brandon Lapallo; Michael Duffield; Briana M Abel; Ferne Pomerantz
Journal:  Exp Brain Res       Date:  2011-03-01       Impact factor: 1.972

5.  Changes in human alpha-motoneurone excitability following mechanical muscle stimuli.

Authors:  D Claus; K R Mills; N M Murray; D R Fish
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

6.  Enhancement of recurrent inhibition by intravenous administration of L-acetylcarnitine in spastic patients.

Authors:  R Mazzocchio; M Schieppati; C Scarpini; A Rossi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

7.  Differential effects of stimulation of the cat's red nucleus on lumbar alpha motoneurones and their Renshaw cells.

Authors:  H D Henatsch; J Meyer-Lohmann; U Windhorst; J Schmidt
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

8.  Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A.

Authors:  Véronique Marchand-Pauvert; Claire Aymard; Louis-Solal Giboin; Federica Dominici; Alessandro Rossi; Riccardo Mazzocchio
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

9.  Muscle weakness and lack of reflex gain adaptation predominate during post-stroke posture control of the wrist.

Authors:  Carel G M Meskers; Alfred C Schouten; Jurriaan H de Groot; Erwin de Vlugt; Bob J J van Hilten; Frans C T van der Helm; Hans J H Arendzen
Journal:  J Neuroeng Rehabil       Date:  2009-07-23       Impact factor: 4.262

10.  Transmission in heteronymous spinal pathways is modified after stroke and related to motor incoordination.

Authors:  Joseph-Omer Dyer; Eric Maupas; Sibele de Andrade Melo; Daniel Bourbonnais; Jean Fleury; Robert Forget
Journal:  PLoS One       Date:  2009-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.